1121P Real-world (RW) data from the sotorasib French pre-market authorization early access program in patients (pts) with KRASG12C driven metastatic non-small cell lung cancer (mNSCLC): Clinical characteristics

Autor: Cadranel, J., Quantin, X., Girard, N., Barlesi, F., Auliac, J.B., Couraud, S., Madroszyk Flandin, A-C., Pabst, L., Rieux, C., Curcio, H., Gille, R., Métivier, A-C., Becht, C., Bylicki, O., Tomasini, P., Veillon, R., Damade, C., Mourad, C., Veillard, C., Lena, H.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1063-S1064
Databáze: ScienceDirect